Evidence map›Paper›PMID 32965168›Full record

ReviewMultiple sclerosis (Houndmills, Basingstoke, England)2022

In vivo imaging of chronic active lesions in multiple sclerosis.

Alberto Calvi, Lukas Haider, Ferran Prados, Carmen Tur, Declan Chard, Frederik Barkhof

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Multiple sclerosis (Houndmills, Basingstoke, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05783934 (Evaluation of the Degree of Demyelination and Remyelination in Multiple Sclerosis), which is not on this map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05783934 nacompletednot on this map

Evaluation of the Degree of Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Positron Emission Tomography With Amyloid Markers (PET-CT 18F-Florbetaben) and Comparison With MRI Findings

TypeinterventionalSponsorIstituti Clinici Scientifici Maugeri SpARan2021 to 2024Enrolled6ConditionsMultiple SclerosisArms18F-florbetaben PET/CT
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Astrocytes in Multiple Sclerosis: Getting to the Core.International journal of molecular sciences · 2026
    Review
  8. TAnnals of clinical and translational neurology · 2026
    Article
  9. Review
  10. First evaluation in multiple sclerosis using PET tracer [European journal of nuclear medicine and molecular imaging · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Alberto CalviQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Unità di neurologia, Associazione Centro 'Dino Ferrari', IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.ORCID 0000-0002-1953-2803
Lukas HaiderQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Ferran PradosQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK/e-Health Centre, Universitat Oberta de Catalunya, Barcelona, Spain.
Carmen TurQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Neurology Department, Luton and Dunstable University Hospital, Luton, UK.
Declan ChardQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, UK.ORCID 0000-0003-3076-2682
Frederik BarkhofQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK/Radiology & Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.ORCID 0000-0003-3543-3706
Luton and Dunstable Hospital · GBNational Hospital for Neurology and Neurosurgery · GBNational Institute for Health Research · GBUniversitat Oberta de Catalunya · ESUniversity College London · GBUniversity of Milan · IT

Funding

Department of Health
6 · The paper itself

Abstract

New clinical activity in multiple sclerosis (MS) is often accompanied by acute inflammation which subsides. However, there is growing evidence that a substantial proportion of lesions remain active well beyond the acute phase. Chronic active lesions are most frequently found in progressive MS and are characterised by a border of inflammation associated with iron-enriched cells, leading to ongoing tissue injury. Identifying imaging markers for chronic active lesions in vivo are thus a major research goal. We reviewed the literature on imaging of chronic active lesion in MS, focussing on 'slowly expanding lesions' (SELs), detected by volumetric longitudinal magnetic resonance imaging (MRI) and 'rim-positive' lesions, identified by susceptibility iron-sensitive MRI. Both SELs and rim-positive lesions have been found to be prognostically relevant to future disability. Little is known about the co-occurrence of rims around SELs and their inter-relationship with other emerging techniques such as dynamic contrast enhancement (DCE) and positron emission tomography (PET).

Indexed as

Multiple SclerosisMultiple Sclerosis, Chronic ProgressiveBrainHumansMagnetic Resonance ImagingPositron-Emission Tomographychronic active lesionsimagingmagnetic resonance imagingMultiple sclerosispositron emission tomography

Identifiers

PMID32965168
PMCPMC8978472
OpenAlexW3088036306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.